Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
15 July 2021 | Story Lunga Luthuli

The Three-Minute Thesis Competition, also known as the ‘3MT’, is an annual competition held at 200 universities around the world. It is open to PhD and master’s students, challenging participants to present their research in just 180 seconds – in a way that is understood by an audience with no background in the research area.

Click here for more information

The competition originated at the University of Queensland, Australia. The UFS Postgraduate School was the first to bring the ‘Three-Minute Thesis’ (3MT) competition to Africa, and it has now become an annual event at the UFS.

The competition aims to assist participants in the development of presentation, research, and academic communication skills, as well as to support the development of research students.

Each faculty will run the 3MT at faculty level. Winners from each faculty will compete against each other during the institutional competition on 1 October 2021 and will stand a chance to win these awesome cash prizes.

UFS INSTITUTIONAL PRIZES FOR 2021 ARE:

Position Prizes 2021
Master’s winner R6 000
Master’s 1st runner-up R4 000
Master’s 2nd runner-up R2 000
PhD winner  R8 000
PhD 1st runner-up R6 000
PhD 2nd runner-up R4 000


Winners of the institutional competition will go ahead to compete against other universities on 29 October 2021.

 


News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept